Literature DB >> 8793902

Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor.

C A Briggs1, D G McKenna.   

Abstract

Responses of the human alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) expressed in Xenopus laevis oocytes were quantified in the presence of barium (10 mM) to prevent secondary activation of Ca(2+)-dependent Cl- currents and atropine (2 microM) to block endogenous muscarinic receptors. Acetylcholine (ACh) elicited responses with EC50 values of 177 +/- 32 microM to 272 +/- 26 microM in different experiments. Responses to ACh (200 microM) were blocked by the nAChR antagonists alpha-bungarotoxin (IC50 = 0.54 +/- 0.04 nM), methyllycaconitine (IC50 = 0.64 +/- 0.08 nM) and mecamylamine (IC50 = 1.8 +/- 02 microM). Additionally, MK-801, a non-competitive blocker of N-methyl-D-aspartate (NMDA) sensitive glutamate receptor channels, inhibited the human alpha 7 nAChR. This effect was not stereoselective; the IC50 for (+)-MK-801 was 15 +/- 3 microM while that for (-)-MK-801 was 14 +/- 3 microM. The inhibition by MK-801, in contrast to methyllycaconitine, was dependent upon cell potential, consistent with a mechanism involving channel blockade. The inhibition by MK-801 reversed slowly (time constant approximately 20 min) compared to that by methyllycaconitine (100% recovery within 10 min). However, MK-801 did not appear to be trapped in the channel because the recovery from inhibition showed little dependence upon stimulation rate or cell potential. Thus, MK-801 acted as a non-stereoselective alpha 7 nAChR inhibitor that was only about 8-fold less potent than the nAChR antagonist mecamylamine and probably acted through channel blockade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793902     DOI: 10.1016/0028-3908(96)00006-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.

Authors:  Clark A Briggs; Jens Halvard Grønlien; Peter Curzon; Daniel B Timmermann; Hilde Ween; Kirsten Thorin-Hagene; Paige Kerr; David J Anderson; John Malysz; Tino Dyhring; Gunnar M Olsen; Dan Peters; William H Bunnelle; Murali Gopalakrishnan
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

2.  Complex Control of Striatal Neurotransmission by Nicotinic Acetylcholine Receptors via Excitatory Inputs onto Medium Spiny Neurons.

Authors:  Valentina Licheri; Oona Lagström; Amir Lotfi; Mary H Patton; Holger Wigström; Brian Mathur; Louise Adermark
Journal:  J Neurosci       Date:  2018-06-25       Impact factor: 6.167

3.  The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats.

Authors:  Alvin V Terry; Jerry J Buccafusco; R Foster Schade; Leah Vandenhuerk; Patrick M Callahan; Wayne D Beck; Elizabeth J Hutchings; James M Chapman; Pei Li; Michael G Bartlett
Journal:  Biochem Pharmacol       Date:  2012-01-08       Impact factor: 5.858

4.  Attenuation of noise-induced hyperactivity in the dorsal cochlear nucleus by pre-treatment with MK-801.

Authors:  M W Criddle; D A Godfrey; J A Kaltenbach
Journal:  Brain Res       Date:  2018-01-09       Impact factor: 3.252

5.  Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats.

Authors:  E S Zakharova; W Danysz; A Y Bespalov
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

6.  Ibogaine and the dopaminergic response to nicotine.

Authors:  I M Maisonneuve; G L Mann; C R Deibel; S D Glick
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

7.  NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.

Authors:  Zhihao Mao; Shengxi He; Christopher Mesnard; Paul Synowicki; Yuning Zhang; Lucy Chung; Alex I Wiesman; Tony W Wilson; Daniel T Monaghan
Journal:  Brain Res       Date:  2019-11-28       Impact factor: 3.252

8.  Regulation of cholinergic phenotype in developing neurons.

Authors:  Xinhuai Liu; Ion R Popescu; Janna V Denisova; Rachael L Neve; Roderick A Corriveau; Andrei B Belousov
Journal:  J Neurophysiol       Date:  2008-03-05       Impact factor: 2.714

9.  Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity.

Authors:  Takashi Miyamoto; Daniel Kim; Joseph A Knox; Erik Johnson; Lennart Mucke
Journal:  J Biol Chem       Date:  2015-11-20       Impact factor: 5.157

10.  A G protein-coupled α7 nicotinic receptor regulates signaling and TNF-α release in microglia.

Authors:  Justin R King; Trudy C Gillevet; Nadine Kabbani
Journal:  FEBS Open Bio       Date:  2017-08-07       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.